TITLE

LOSARTAN ATTENUATED CARDIOMYOCYTE APOPTOSIS BY INCREASING AKT ACTIVITY IN AORTIC BANDED RATS WITH CHRONIC HEART FAILURE

PUB. DATE
October 2010
SOURCE
Heart;Oct2010 Supplement, pA8
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Losartan Attenuated Cardiomyocyte Apoptosis by Increasing AKT Activity in Aortic Banded Rays With Chronic Heart Failure" by Deming Fu and colleagues is presented.
ACCESSION #
66245601

 

Related Articles

  • HEAAL: High-dose losartan associated with reduced rate of death or hospitalization. Raible, Eric // Cardiology Today;Dec2009, Vol. 12 Issue 12, p14 

    The article discusses a study which showed that a higher dose of the angiotensin receptor-blocker losartan was linked with a reduction in mortality or heart failure hospitalization, presented at the American Heart Association (AHA) Scientific Sessions in November 2009 in Orlando, Florida.

  • ARB may help block muscle wasting in elderly patients. Moberly, Tom // GP: General Practitioner;5/20/2011, p23 

    The article reports that according to a study angiotensin-receptor blocker (ARB) losartan could prevent muscle wasting in elderly patients. he researchers said their findings provided 'he basis for new therapeutic strategies in patients with sarcopenia. losartan is licensed to treat hypertension...

  • 166 Angiotensin-2 receptor blockade with losartan improves left ventricular function at rest and post-exercise in heart failure patients with preserved ejection fraction. Berezin, A. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 3 Issue 1, p33 

    An abstract of the study "Angiotensin-2 Receptor Blockade With Losartan Improves Left Ventricular Function at Rest and Post-Exercise in Heart Failure Patients With Preserved Ejection Fraction," by A. Berezin is presented.

  • Losartan more cost effective than candesartan - or is it?  // PharmacoEconomics & Outcomes News;2/19/2011, Issue 622, p2 

    The article deals with a study conducted by researchers from Great Britain which found that generic losartan is more cost effective than canderstan for the treatment of hypertension and heart failure.

  • Losartan has a higher death risk than candesartan.  // Australian Journal of Pharmacy;Aug2011, Vol. 92 Issue 1095, p84 

    The article focuses on the study which assesses the association of candesartan against losartan with all-cause mortality in patients having heart failure using Kaplan-Meier method and univariate and multivariate proportional hazard regression models, conducted by M. Eklind-Cervenka and colleagues.

  • MECHANISMS OF LOSARTAN ATTENUATES VENTRICULAR REMODELLING AND CARDIAC FUNCTION IN AORTIC BANDED RATS WITH CHRONIC HEART FAILURE.  // Heart;Oct2010 Supplement, pA11 

    An abstract of the article "Mechanism of Losartan Attenuates Ventricular Remodelling and Cardiac Function in Aortic Banded Rats With Chronic Heart Failure" by Fu Deming and colleagues is presented.

  • Regression of ECG-LVH is Associated with Lower Risk of New-Onset Heart Failure and Mortality in Patients with Isolated Systolic Hypertension; The LIFE Study. Larstorp, Anne Cecilie K.; Okin, Peter M.; Devereux, Richard B.; Olsen, Michael H.; Ibsen, Hans; Dahlöf, Björn; Kjeldsen, Sverre E.; Wachtell, Kristian // American Journal of Hypertension;Oct2012, Vol. 25 Issue 10, p1101 

    BackgroundHypertension and electrocardiographic left ventricular hypertrophy (ECG-LVH) are strong predictors of heart failure (HF). It is unclear whether regression of ECG-LVH during treatment predicts less new-onset HF in patients with isolated systolic hypertension (ISH).MethodsA total of...

  • Losartan vs Candesartan for Heart Failure. Lund, Lars H.; Benson, Lina; Svanström, Henrik; Pasternak, Björn; Hviid, Anders // JAMA: Journal of the American Medical Association;7/25/2012, Vol. 308 Issue 4, p336 

    A letter to the editor is presented in response to the article "Association of treatment with losartan vs candesartan and mortality among patients with heart failure" by Hviid A. and colleagues in the 2012 issue along with a reply from the authors to the same.

  • Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure. Eklind-Cervenka, Maria; Benson, Lina; Dahlström, Ulf; Edner, Magnus; Rosenqvist, Mårten; Lund, Lars H. // JAMA: Journal of the American Medical Association;1/12/2011, Vol. 305 Issue 2, p175 

    The article focuses on a study which assessed the effectiveness of candesartan compared with losartan in lowering all-cause mortality rate in patients with heart failure (HF). The study used the Swedish Heart Failure Registry. The main outcome measure of the study is cited. A 90% one-year...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics